The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer

This publication has 30 references indexed in Scilit:

• An immunohistochemical study of c‐erbb‐2 protein in gastric carcinomas and lymph‐node metastases: Is the c‐erbB‐2 protein really a prognostic indicator?
  International Journal of Cancer, 1993
• Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma
  Cancer, 1992
• c‐erbB‐2 proto‐oncogene expression and its relationship to survival in gastric carcinoma: An immunohistochemical study on archival material
  International Journal of Cancer, 1991
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.
  Gut, 1987
• Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive System
  The Lancet Healthy Longevity, 1986
• Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bank
  International Journal of Cancer, 1984
• Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
  Journal of Clinical Pathology, 1984
• A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms
  British Journal of Surgery, 1979
• Human chorionic gonadotrophins (hCG) in nontrophoblastic neoplasms.Assessment of abnormalities of hCG and CEA in bronchogenic and digestive neoplasms
  Cancer, 1976